Preventing Substance Use Among Incarcerated Youth Through Addressing Posttraumatic Stress
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 28
- 试验地点
- 1
- 主要终点
- Child PTSD Symptom Scale (CPSS)
研究概览
简要总结
This pilot study, conducted in partnership with juvenile detention centers, evaluates an adapted CBITS-RTM intervention delivered in a detention school setting.
详细描述
The study examines the intervention's feasibility and acceptability, as well as its effectiveness in reducing incarcerated youth's posttraumatic stress symptoms, improving academic functioning, and decreasing intentions to use substances post-release.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 13 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Youth must 1) be currently incarcerated in a partnering juvenile detention center, 2) be between 13-18 years of age, and 3) have a minimum of 3 months remaining on their sentence (i.e., sufficient time required to complete CBITS-RTM). Youth will complete a screening with a study team member involving the 2-item Abbreviated PTSD Checklist-Civilian version, with scores ≥4 considered a positive screen
- •Clinicians are eligible if they are behavioral health staff working with youth at the detention school..
排除标准
- •Observable cognitive or developmental delays or active psychosis that would interfere with completing consent, assessment or intervention.
研究组 & 干预措施
Adapted CBITS-RTM Intervention
干预措施: Adapted Cognitive Behavioral Intervention for Trauma in Schools (CBITS) with a Racial Trauma Module (RTM) (Behavioral)
结局指标
主要结局
Child PTSD Symptom Scale (CPSS)
时间窗: Baseline, 3 months post-baseline
The CPSS is used to measure posttraumatic stress among youth (8-18 years). It assesses past month posttraumatic stress symptom severity and impairment of endorsed symptoms on daily functioning. Scores range from 0-80, with 31+ indicating probable PTSD.
次要结局
- Youth Alcohol and Drug Use Survey(Baseline, 3 months post-baseline)
- Texas Christian University (TCU) Drug Screen(Baseline, 3-months post-baseline)